Table 2.
Baseline Ocular Comparison Between Study and Non-Study Eye
| Study Eye | Non-Study Eye | |
|---|---|---|
| Mean logMAR BCVA (SD) a | 0.129 (0.149) | 0.033 (0.067) |
| IOP (mm Hg), mean (SD) Cataract, n (%) | 15.85 (2.91) | 16.10 (3.13) |
| Clear lens | 10 (50) | 9 (45) |
| Trace NS | 2 (10) | 2 (10) |
| 1 to 2+ | 7 (35) | 8 (40) |
| 3+ | 1 (5) | 1 (5) |
| Pseudophakia, n (%) | 3 (15) | 2 (10) |
| RVO Classification, n (%) | ||
| BRVO | 11 (55) | |
| CRVO | 9 (45) | |
| Imaging data (at/before study visit) | ||
| CFT (µm), mean (SD) | 286 (38) | 273 (29) |
| Presence of intraretinal fluid | 8 (40%) | 0 |
| Presence of subretinal fluid | 1 (5%) | 0 |
a
Indicates that a P value comparing the study versus non-study eye for the marked parameter is significant and < 0.05.
All data is presented as number of eyes (n) out of the cohort (20), followed by a percent, unless otherwise indicated.
BCVA, best corrected visual acuity; IOP, intraocular pressure; BRVO, branched retinal vein occlusion; CRVO, central retinal vein occlusion; CFT, central foveal thickness.